Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 27:10.1097/SLA.0000000000006354.
doi: 10.1097/SLA.0000000000006354. Online ahead of print.

A Randomized Controlled Trial of the Implementation of BREASTChoice , a Multilevel Breast Reconstruction Decision Support Tool With Personalized Risk Prediction

Mary C Politi  1 , Terence M Myckatyn  1 , Krista Cooksey  1 , Margaret A Olsen  2 , Rachel M Smith  3 , Randi Foraker  2 , Katelyn Parrish  2 , Crystal Phommasathit  3 , Guy Brock  3 , Sarah Janse  3   4 , Janine Guglielmino  5 , Anne Peled  6 , Paul B Mills  7 , Sherrill Jackson  8 , Clara N Lee  3
Affiliations

A Randomized Controlled Trial of the Implementation of BREASTChoice , a Multilevel Breast Reconstruction Decision Support Tool With Personalized Risk Prediction

Mary C Politi et al. Ann Surg. .

Erratum in

Abstract

Objective: To implement the BREASTChoice decision tool into the electronic health record and evaluate its effectiveness.

Background: BREASTChoice , is a multilevel decision tool that: 1) educates patients about breast reconstruction; 2) estimates personalized risk of complications; 3) clarifies patient preferences; and 4) informs clinicians about patients' risk and preferences.

Methods: A multisite randomized controlled trial enrolled adult women with stage 0-III breast malignancy undergoing mastectomy. Participants were randomized to BREASTChoice or a control website. A survey assessed knowledge, preferences, decisional conflict, shared decision-making, preferred treatment, and usability. We conducted intent-to-treat (ITT), per-protocol (PP) analyses (those randomized to BREASTChoice who accessed the tool), and stratified analyses.

Results: 23/25 eligible clinicians enrolled. 369/761 (48%) contacted patients enrolled and were randomized. Patients' average age was 51 years; 15% were older than 65. BREASTChoice participants had higher knowledge than control participants (ITT: mean 70.6 vs. 67.4, P =0.08; PP: mean 71.4 vs. 67.4, P =0.03), especially when stratified by site (ITT: P =0.04, PP: P =0.01), age (ITT: P =0.04, PP: P =0.02), and race (ITT: P =0.04, PP: P =0.01). BREASTChoice did not improve decisional conflict, match between preferences and treatment, or shared decision-making. In PP analyses, fewer high-risk patients using BREASTChoice chose reconstruction. BREASTChoice had high usability.

Conclusions: BREASTChoice is a novel decision tool incorporating risk prediction, patient education, and clinician engagement. Patients using BREASTChoice had higher knowledge; older adults and those from racially minoritized backgrounds especially benefitted. There was no impact on other decision outcomes. Future studies should overcome implementation barriers and specifically examine decision outcomes among high-risk patients.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1:
Figure 1:
BREASTChoice Patient Homepage
Figure 2:
Figure 2:
Sample Risk Display
Figure 3:
Figure 3:
Sample Clinician Summary
Figure 4:
Figure 4:
CONSORT Flow Diagram
See this image and copyright information in PMC

References

    1. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol 2010;17(10):2554–62. doi: 10.1245/s10434-010-1091-3 [published Online First: 2010/05/13] - DOI - PubMed
    1. Kummerow KL, Du L, Penson DF, et al. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 2015;150(1):9–16. doi: 10.1001/jamasurg.2014.2895 [published Online First: 2014/11/20] - DOI - PubMed
    1. Jagsi R, Li Y, Morrow M, et al. Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors. Ann Surg 2015;261(6):1198–206. doi: 10.1097/sla.0000000000000908 [published Online First: 2015/02/06] - DOI - PMC - PubMed
    1. Shammas RL, Hung A, Mullikin A, et al. Patient Preferences for Postmastectomy Breast Reconstruction. JAMA Surg 2023;158(12):1285–92. doi: 10.1001/jamasurg.2023.4432 [published Online First: 2023/09/27] - DOI - PMC - PubMed
    1. Lee CN, Ubel PA, Deal AM, et al. How Informed Is the Decision About Breast Reconstruction After Mastectomy?: A Prospective, Cross-sectional Study. Ann Surg 2016;264(6):1103–09. doi: 10.1097/SLA.0000000000001561 - DOI - PMC - PubMed

LinkOut - more resources